Walgreens Effervescent Cold Relief Plus 325 mg/1
Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate · TABLET, EFFERVESCENT · Walgreens
Walgreens Effervescent Cold Relief Plus is a tablet, effervescent containing aspirin, chlorpheniramine maleate, phenylephrine bitartrate at 325 mg/1, taken oral. Manufactured by Walgreens.
Key Facts
- Brand Name
- Walgreens Effervescent Cold Relief Plus
- Generic Name
- Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate
- NDC Code (Product)
0363-0875- Manufacturer
- Walgreens
- Strength
- 325 mg/1
- Dosage Form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
- Marketing Start
- 10/24/2014
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Uses ■ temporarily relieves these symptoms of the common cold: ■ sneezing ■ nasal congestion ■ sore throat ■ headache ■ minor aches and pains ■ runny nose ■ sinus congestion and pressure ■ temporarily reduces fever
Dosage & Administration
Directions ■ do not use more than directed (see overdose warning) ■ adults and children 12 years and over: take 2 tablets completely dissolved in 4 oz of water every 4 hours ■ do not take more than 8 tablets in 24 hours ■ children under 12 years: ask a doctor
Warnings
Warnings Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness. Allergy alert: Aspirin may cause a severe allergic reaction which may include: ■ hives ■ facial swelling ■ asthma (wheezing) ■ shock Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you ■ are age 60 or older ■ have had stomach ulcers or bleeding problems ■ take a blood thinning (anticoagulant) or steroid drug ■ take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) ■ have 3 or more alcoholic drinks every day while using this product ■ take more or for a longer time than directed Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly. Do not use to sedate children
Frequently Asked Questions
What is Walgreens Effervescent Cold Relief Plus used for?
Walgreens Effervescent Cold Relief Plus contains Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate. It is a tablet, effervescent taken oral. Consult your doctor for specific uses.
Is Walgreens Effervescent Cold Relief Plus a controlled substance?
Walgreens Effervescent Cold Relief Plus is not classified as a controlled substance by the DEA.
What is the generic name for Walgreens Effervescent Cold Relief Plus?
The generic name for Walgreens Effervescent Cold Relief Plus is Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate. There are 11 other brand versions of Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate.
What is the NDC code for Walgreens Effervescent Cold Relief Plus 325 mg/1?
The NDC (National Drug Code) for Walgreens Effervescent Cold Relief Plus 325 mg/1 is 0363-0875, listed by Walgreens.
Other Aspirin, Brands
See all →- Effervescent Orange Cold Relief325 mg/137808-768
- Effervescent Cold Relief325 mg/153943-873
- Family Wellness Effervescent Cold Relief Orange325 mg/155319-875
- Best Choice Effervescent Cold Relief325 mg/163941-873
- Kroger Effervescent Cold Relief325 mg/130142-875
- Alka-Seltzer Plus Cold Sparkling Original325 mg/10280-1520
- Equaline Effervescent Cold Relief325 mg/141163-768
- Top Value Effervescent Cold Relief - Orange325 mg/150201-8752
- Effervescent Orange Cold Relief325 mg/141250-123
- Top Value Effervescent Cold Relief325 mg/150201-7682
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)